{"entity":{"type":"insider","cik":"0001862146","url":"/insider/0001862146","json_url":"/insider/0001862146.json","name":"Turner Christopher Durant","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":6,"first":"2023-06-07","last":"2026-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Turner Christopher Durant","source":"filing","n_filings":6,"first_seen":"2023-06-07","last_seen":"2026-01-07"}],"transactions":[{"id":6015928,"accession":"0001193125-26-006571","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-006571","line_url":"/filing/0001193125-26-006571","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3181.0,"shares_display":"3,181","price_per_share":97.16482238289846,"price_display":"97.16","price_state":"stated","total_value":309081.3,"total_display":"309,081.30","total_whole":"309,081","shares_owned_after":55355.0,"shares_owned_after_display":"55,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider","n_lines":3},{"id":6015921,"accession":"0001193125-26-006571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-006571","line_url":"/filing/0001193125-26-006571","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4236.0,"shares_display":"4,236","price_per_share":97.31800991501416,"price_display":"97.32","price_state":"stated","total_value":412239.09,"total_display":"412,239.09","total_whole":"412,239","shares_owned_after":58628.0,"shares_owned_after_display":"58,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider","n_lines":4},{"id":4375523,"accession":"0000950170-25-003490","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-003490","line_url":"/filing/0000950170-25-003490","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4016.0,"shares_display":"4,016","price_per_share":79.68351842629482,"price_display":"79.68","price_state":"stated","total_value":320009.01,"total_display":"320,009.01","total_whole":"320,009","shares_owned_after":62547.0,"shares_owned_after_display":"62,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider","n_lines":3},{"id":8190064,"accession":"0001209191-23-052349","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-052349","line_url":"/filing/0001209191-23-052349","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7995.0,"shares_display":"7,995","price_per_share":54.03762351469668,"price_display":"54.04","price_state":"stated","total_value":432030.8,"total_display":"432,030.80","total_whole":"432,031","shares_owned_after":19843.0,"shares_owned_after_display":"19,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-06","scope":"insider","n_lines":6},{"id":8546307,"accession":"0001209191-23-043700","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-043700","line_url":"/filing/0001209191-23-043700#line-4","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2665.0,"shares_display":"2,665","price_per_share":48.93,"price_display":"48.93","price_state":"stated","total_value":130398.45,"total_display":"130,398.45","total_whole":"130,398","shares_owned_after":14513.0,"shares_owned_after_display":"14,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-28","scope":"insider"},{"id":8546298,"accession":"0001209191-23-043700","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043700","line_url":"/filing/0001209191-23-043700#line-2","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2365.0,"shares_display":"2,365","price_per_share":46.85,"price_display":"46.85","price_state":"stated","total_value":110800.25,"total_display":"110,800.25","total_whole":"110,800","shares_owned_after":14513.0,"shares_owned_after_display":"14,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-28","scope":"insider"},{"id":8254595,"accession":"0001209191-23-043226","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-043226","line_url":"/filing/0001209191-23-043226#line-4","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":46.82,"price_display":"46.82","price_state":"stated","total_value":9364.0,"total_display":"9,364.00","total_whole":"9,364","shares_owned_after":14513.0,"shares_owned_after_display":"14,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-24","scope":"insider"},{"id":8254589,"accession":"0001209191-23-043226","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043226","line_url":"/filing/0001209191-23-043226#line-2","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":46.8,"price_display":"46.80","price_state":"stated","total_value":4680.0,"total_display":"4,680.00","total_whole":"4,680","shares_owned_after":14513.0,"shares_owned_after_display":"14,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-24","scope":"insider"},{"id":7835557,"accession":"0001209191-23-035126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035126","line_url":"/filing/0001209191-23-035126#line-2","is_derivative":false,"issuer_cik":"0001861560","issuer_name":"Nuvalent, Inc.","issuer_ticker":"NUVL","issuer_name_source":null,"issuer_url":"/issuer/0001861560","owner_cik":"0001862146","owner_name":"Turner Christopher Durant","owner_display_name":"Turner Christopher Durant","owner_url":"/insider/0001862146","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10235.0,"shares_display":"10,235","price_per_share":44.86,"price_display":"44.86","price_state":"stated","total_value":459142.1,"total_display":"459,142.10","total_whole":"459,142","shares_owned_after":14513.0,"shares_owned_after_display":"14,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001861560","name":"Nuvalent, Inc.","url":"/issuer/0001861560","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2023-06-07","last_seen":"2026-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001862146","retrieved_at":"2026-08-22T15:31:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}